Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Female reproduction and abnormal uterine bleeding after COVID-19 vaccination

  • Haerin Paik (Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital) ;
  • Seul Ki Kim (Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital)
  • Received : 2023.01.29
  • Accepted : 2023.04.21
  • Published : 2023.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Coronavirus disease 2019 (COVID-19) vaccines have been widely administered throughout the global community to minimize the morbidity and mortality caused by the COVID-19 pandemic. Although generally well-tolerated, these vaccines have generated some unwanted consequences, including thrombosis and menstrual irregularities. The effect of vaccination on female reproductive function has also been questioned. The aim of this review is to give readers a clear understanding of the effects of COVID-19 vaccines on thrombosis, reproductive function, and menstrual irregularities by systemically analyzing the available literature. The available evidence suggests that COVID-19 vaccines have a minimal impact on ovarian reserve. Furthermore, in vitro fertilization outcomes after COVID-19 vaccination remain unimpaired compared to those who did not receive the vaccines. Current evidence supports a certain degree of impact of COVID-19 vaccines on the menstrual cycle, with the most frequent alteration being menstrual irregularity, followed by menorrhagia. These changes are generally well-tolerated and transient, lasting less than 2 months. This review, by providing information with up-to-date references on this issue, may enhance readers' understanding of the impact of COVID-19 vaccines on female reproductive function and the menstrual cycle.

Keywords

References

  1. World Health Organization. WHO coronavirus (COVID-19) dashboard [Internet]. WHO; 2023 [cited 2023 May 3]. Available from: https://covid19.who.int/
  2. Schultz NH, Sorvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med 2021;384:2124-30. https://doi.org/10.1056/NEJMoa2104882
  3. Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M, et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med 2021;384:2202-11. https://doi.org/10.1056/NEJMoa2105385
  4. Center for Biologics Evaluation and Research Office of Biostatistics and Epidemiology. CBER Surveillance Program: background rates of adverse events of special interest for COVID-19 vaccine safety monitoring protocol 2021 [Internet]. FDA; 2021 [cited 2023 May 3]. Available from: https://bestinitiative.org/wp-content/uploads/2021/02/C19-Vaccine-Safety-AESI-Background-Rate-Protocol-FINAL-2020.pdf
  5. Pawlowski C, Rincon-Hekking J, Awasthi S, Pandey V, Lenehan P, Venkatakrishnan AJ, et al. Cerebral venous sinus thrombosis is not significantly linked to COVID-19 vaccines or non-COVID vaccines in a large multi-state health system. J Stroke Cerebrovasc Dis 2021;30:105923.
  6. Pottegard A, Lund LC, Karlstad O, Dahl J, Andersen M, Hallas J, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ 2021;373:n1114.
  7. Tobaiqy M, Elkout H, MacLure K. Analysis of thrombotic adverse reactions of COVID-19 AstraZeneca vaccine reported to EudraVigilance database. Vaccines (Basel) 2021;9:393.
  8. Smadja DM, Yue QY, Chocron R, Sanchez O, Lillo-Le Louet A. Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase. Eur Respir J 2021;58:2100956.
  9. Al-Ali D, Elshafeey A, Mushannen M, Kawas H, Shafiq A, Mhaimeed N, et al. Cardiovascular and haematological events post COVID-19 vaccination: a systematic review. J Cell Mol Med 2022;26:636-53. https://doi.org/10.1111/jcmm.17137
  10. Bilotta C, Perrone G, Adelfio V, Spatola GF, Uzzo ML, Argo A, et al. COVID-19 vaccine-related thrombosis: a systematic review and exploratory analysis. Front Immunol 2021;12:729251.
  11. Flynn AC, Kavanagh K, Smith AD, Poston L, White SL. The impact of the COVID-19 pandemic on pregnancy planning behaviors. Womens Health Rep (New Rochelle) 2021;2:71-7. https://doi.org/10.1089/whr.2021.0005
  12. American Society for Reproductive Medicine. Patient management and clinical recommendations during the coronavirus (COVID-19) pandemic [Internet]. ASRM; 2020 [cited 2023 May 3]. Available from: https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/covid-19/covidtaskforceupdate11.pdf
  13. Bowman CJ, Bouressam M, Campion SN, Cappon GD, Catlin NR, Cutler MW, et al. Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine. ReprodToxicol 2021;103:28-35. https://doi.org/10.1016/j.reprotox.2021.05.007
  14. Moolhuijsen LM, Visser JA. Anti-Mullerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab 2020;105:3361-73. https://doi.org/10.1210/clinem/dgaa513
  15. Cedars MI. Evaluation of female fertility-AMH and ovarian reserve testing. J Clin Endocrinol Metab 2022;107:1510-9. https://doi.org/10.1210/clinem/dgac039
  16. van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, et al. Serum antiMullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005;83:979-87. https://doi.org/10.1016/j.fertnstert.2004.11.029
  17. Bentzen JG, Forman JL, Larsen EC, Pinborg A, Johannsen TH, Schmidt L, et al. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age. Hum Reprod 2013;28:247-55. https://doi.org/10.1093/humrep/des356
  18. Bentov Y, Beharier O, Moav-Zafrir A, Kabessa M, Godin M, Greenfield CS, et al. Ovarian follicular function is not altered by SARSCoV-2 infection or BNT162b2 mRNA COVID-19 vaccination. Hum Reprod 2021;36:2506-13.
  19. Aharon D, Lederman M, Ghofranian A, Hernandez-Nieto C, Canon C, Hanley W, et al. In vitro fertilization and early pregnancy outcomes after coronavirus disease 2019 (COVID-19) vaccination. Obstet Gynecol 2022;139:490-7. https://doi.org/10.1097/AOG.0000000000004713
  20. Wu Y, Cao M, Lin Y, Xu Z, Liang Z, Huang Q, et al. Inactivated COVID-19 vaccination does not affect in vitro fertilization outcomes in women. Hum Reprod 2022;37:2054-62. https://doi.org/10.1093/humrep/deac160
  21. Huang J, Xia L, Lin J, Liu B, Zhao Y, Xin C, et al. No effect of inactivated SARS-CoV-2 vaccination on in vitro fertilization outcomes: a propensity score-matched study. J Inflamm Res 2022;15:839-49. https://doi.org/10.2147/JIR.S347729
  22. Requena A, Vergara V, Gonzalez-Ravina C, Ruiz ME, Cruz M. The type of SARS-CoV-2 vaccine does not affect ovarian function in assisted reproduction cycle. Fertil Steril 2023;119:618-23. https://doi.org/10.1016/j.fertnstert.2022.12.022
  23. Cao M, Wu Y, Lin Y, Xu Z, Liang Z, Huang Q, et al. Inactivated Covid-19 vaccine did not undermine live birth and neonatal outcomes of women with frozen-thawed embryo transfer. Hum Reprod 2022;37:2942-51. https://doi.org/10.1093/humrep/deac220
  24. Odeh-Natour R, Shapira M, Estrada D, Freimann S, Tal Y, Atzmon Y, et al. Does mRNA SARS-CoV-2 vaccine in the follicular fluid impact follicle and oocyte performance in IVF treatments? Am J Reprod Immunol 2022;87:e13530.
  25. Orvieto R, Noach-Hirsh M, Segev-Zahav A, Haas J, Nahum R, Aizer A. Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle? Reprod Biol Endocrinol 2021;19:69.
  26. Avraham S, Kedem A, Zur H, Youngster M, Yaakov O, Yerushalmi GM, et al. Coronavirus disease 2019 vaccination and infertility treatment outcomes. Fertil Steril 2022;117:1291-9. https://doi.org/10.1016/j.fertnstert.2022.02.025
  27. Zhao Y, Zhao Y, Ai A, Jin L. Association of inactivated COVID-19 vaccination with in vitro fertilization and early pregnancy outcomes. J Med Virol 2023;95:e28432.
  28. Brandao P, Pellicer A, Meseguer M, Remohi J, Garrido N, Garcia-Velasco JA. COVID-19 mRNA vaccines have no effect on endometrial receptivity after euploid embryo transfer. Reprod Biomed Online 2022;45:688-95. https://doi.org/10.1016/j.rbmo.2022.05.017
  29. Alghamdi AN, Alotaibi MI, Alqahtani AS, Al Aboud D, Abdel-Moneim AS. BNT162b2 and ChAdOx1 SARS-CoV-2 post-vaccination side-effects among Saudi vaccinees. Front Med (Lausanne) 2021;8:760047.
  30. Anjorin AA, Odetokun IA, Nyandwi JB, Elnadi H, Awiagah KS, Eyedo J, et al. Public health surveillance for adverse events following COVID-19 vaccination in Africa. Vaccines (Basel) 2022;10:546.
  31. Cheng Y, Li T, Zheng Y, Xu B, Bi Y, Hu Y, et al. Self-reported adverse events among Chinese healthcare workers immunized with COVID-19 vaccines composed of inactivated SARS-CoV-2. Hum Vaccin Immunother 2022;18:2064134.
  32. Dar-Odeh N, Abu-Hammad O, Qasem F, Jambi S, Alhodhodi A, Othman A, et al. Long-term adverse events of three COVID-19 vaccines as reported by vaccinated physicians and dentists, a study from Jordan and Saudi Arabia. Hum Vaccin Immunother 2022;18:2039017.
  33. Girardi G, Bremer AA. Scientific evidence supporting coronavirus disease 2019 (COVID-19) vaccine efficacy and safety in people planning to conceive or who are pregnant or lactating. Obstet Gynecol 2022;139:3-8.
  34. Lagana AS, Veronesi G, Ghezzi F, Ferrario MM, Cromi A, Bizzarri M, et al. Evaluation of menstrual irregularities after COVID-19 vaccination: results of the MECOVAC survey. Open Med (Wars) 2022;17:475-84. https://doi.org/10.1515/med-2022-0452
  35. Issakov G, Tzur Y, Friedman T, Tzur T. Abnormal uterine bleeding among COVID-19 vaccinated and recovered women: a national survey. Reprod Sci 2023;30:713-21. https://doi.org/10.1007/s43032-022-01062-2
  36. Edelman A, Boniface ER, Male V, Cameron ST, Benhar E, Han L, et al. Association between menstrual cycle length and covid-19 vaccination: global, retrospective cohort study of prospectively collected data. BMJ Med 2022;1:e000297.
  37. Wong KK, Heilig CM, Hause A, Myers TR, Olson CK, Gee J, et al. Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020-January, 2022: an observational cohort study. Lancet Digit Health 2022;4:e667-75. https://doi.org/10.1016/S2589-7500(22)00125-X
  38. Farland LV, Khan SM, Shilen A, Heslin KM, Ishimwe P, Allen AM, et al. COVID-19 vaccination and changes in the menstrual cycle among vaccinated persons. Fertil Steril 2023;119:392-400. https://doi.org/10.1016/j.fertnstert.2022.12.023
  39. Rodriguez Quejada L, Toro Wills MF, Martinez-Avila MC, Patino-Aldana AF. Menstrual cycle disturbances after COVID-19 vaccination. Womens Health (Lond) 2022;18:17455057221109375.
  40. Muhaidat N, Alshrouf MA, Azzam MI, Karam AM, Al-Nazer MW, AlAni A. Menstrual symptoms after COVID-19 vaccine: a cross-sectional investigation in the MENA region. Int J Womens Health 2022;14:395-404. https://doi.org/10.2147/IJWH.S352167